{ "@context": "https://schema.org", "@type": [ "Organization", "ResearchOrganization" ], "@id": "https://www.meliordiscovery.com/#organization", "name": "Melior Discovery", "legalName": "Melior Discovery Inc.", "alternateName": "Melior", "url": "https://www.meliordiscovery.com/", "logo": { "@type": "ImageObject", "@id": "https://www.meliordiscovery.com/#logo", "url": "https://www.meliordiscovery.com/wp-content/uploads/2020/12/Layer-2.svg", "contentUrl": "https://www.meliordiscovery.com/wp-content/uploads/2020/12/Layer-2.svg", "width": 600, "height": 200, "caption": "Melior Discovery" }, "image": { "@id": "https://www.meliordiscovery.com/#logo" }, "slogan": "Capture the Untapped Value of Therapeutics", "description": "Preclinical contract research organization specializing in in vivo phenotypic drug screening, efficacy profiling, and therapeutic indication discovery.", "foundingDate": "2005", "founder": [ { "@type": "Person", "@id": "https://www.meliordiscovery.com/#andrew-reaume", "name": "Andrew Reaume", "honorificSuffix": "PhD, MBA", "jobTitle": "President and CEO, Co-Founder", "url": "https://www.meliordiscovery.com/management-team/", "worksFor": { "@id": "https://www.meliordiscovery.com/#organization" } }, { "@type": "Person", "name": "Michael Saporito", "honorificSuffix": "PhD", "jobTitle": "Co-Founder", "worksFor": { "@id": "https://www.meliordiscovery.com/#organization" } } ], "address": { "@type": "PostalAddress", "streetAddress": "860 Springdale Drive, Suite 500", "addressLocality": "Exton", "addressRegion": "PA", "postalCode": "19341", "addressCountry": "US" }, "areaServed": "Worldwide", "contactPoint": { "@type": "ContactPoint", "telephone": "+1-610-280-0633", "faxNumber": "+1-610-280-0637", "contactType": "sales", "areaServed": "Worldwide", "availableLanguage": "en" }, "identifier": [ { "@type": "PropertyValue", "propertyID": "ROR", "value": "https://ror.org/049ektt11" }, { "@type": "PropertyValue", "propertyID": "ISNI", "value": "0000000459121181" } ], "hasCredential": [ { "@type": "EducationalOccupationalCredential", "credentialCategory": "Accreditation", "name": "AAALAC International Accreditation", "recognizedBy": { "@type": "Organization", "name": "AAALAC International", "url": "https://www.aaalac.org/" } }, { "@type": "EducationalOccupationalCredential", "credentialCategory": "License", "name": "DEA Controlled Substance License, Schedules I-V", "recognizedBy": { "@type": "GovernmentOrganization", "name": "United States Drug Enforcement Administration" } }, { "@type": "EducationalOccupationalCredential", "credentialCategory": "Certification", "name": "Great Place to Work Certified", "recognizedBy": { "@type": "Organization", "name": "Great Place to Work Institute", "url": "https://www.greatplacetowork.com/" } } ], "award": [ "CRO of the Year 2023, Life Sciences Review", "Top 20 CRO, Pharma Tech Outlook" ], "knowsAbout": [ "Preclinical drug development", "In vivo pharmacology", "Phenotypic screening", "Drug repositioning", "Drug repurposing", "Therapeutic indication discovery", "Efficacy modeling", "Oncology", "Neurology", "Pain and neuropathic pain", "Metabolic disease", "Cardiovascular disease", "Inflammation and arthritis", "Gastrointestinal disease", "Pulmonary disease", "Psychiatric and cognitive disorders", "Aging and healthspan" ], "hasOfferCatalog": { "@type": "OfferCatalog", "@id": "https://www.meliordiscovery.com/#services", "name": "In Vivo Pharmacology Services", "itemListElement": [ { "@type": "OfferCatalog", "name": "In Vivo Pharmacology Platforms", "url": "https://www.meliordiscovery.com/in-vivo-pharmacology-platforms/", "itemListElement": [ { "@type": "Offer", "itemOffered": { "@type": "Service", "@id": "https://www.meliordiscovery.com/theratrace/#service", "name": "theraTRACE®", "url": "https://www.meliordiscovery.com/theratrace/", "provider": { "@id": "https://www.meliordiscovery.com/#organization" }, "description": "Proprietary in vivo phenotypic screening platform of approximately 40 customizable animal models for drug repositioning, drug repurposing, and therapeutic indication discovery." } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "@id": "https://www.meliordiscovery.com/opioidtrace/#service", "name": "opioidTRACE®", "url": "https://www.meliordiscovery.com/opioidtrace/", "provider": { "@id": "https://www.meliordiscovery.com/#organization" }, "description": "In vivo pharmacology platform for analgesic research, evaluating acute and chronic pain pathways, respiratory depression, gastric motility, and abuse liability to identify non-opioid or reduced-liability analgesics." } }, { "@type": "Offer", "itemOffered": { "@type": "Service", "@id": "https://www.meliordiscovery.com/in-vivo-pharmacology-platforms/immuno-theratrace/#service", "name": "immuno-theraTRACE®", "url": "https://www.meliordiscovery.com/in-vivo-pharmacology-platforms/immuno-theratrace/", "provider": { "@id": "https://www.meliordiscovery.com/#organization" }, "description": "In vivo oncology platform for screening immune-modulating agents across a range of tumor types, offering high-throughput and lead-candidate study designs." } } ] }, { "@type": "OfferCatalog", "name": "In Vivo Disease Models", "url": "https://www.meliordiscovery.com/in-vivo-efficacy-models/", "itemListElement": [ { "@type": "Offer", "itemOffered": { "@type": "Service", "@id": "https://www.meliordiscovery.com/in-vivo-efficacy-models/#service", "name": "In Vivo Disease Models", "url": "https://www.meliordiscovery.com/in-vivo-efficacy-models/", "provider": { "@id": "https://www.meliordiscovery.com/#organization" }, "description": "A suite of more than 150 validated in vivo efficacy models in rats and mice spanning 14 therapeutic areas, plus custom model development and literature replication." } } ] } ] }, "sameAs": [ "https://en.wikipedia.org/wiki/Melior_Discovery", "https://www.wikidata.org/wiki/Q6812559", "https://ror.org/049ektt11", "https://www.linkedin.com/company/melior-discovery", "https://www.crunchbase.com/organization/melior-discovery", "https://twitter.com/melior_discover", "https://www.facebook.com/Melior-Discovery-1397620873638652/" ] }

Accelerate your preclinical drug development program

In Vivo Disease Models

With more than 150 validated animal models (rat and mouse), our catalog boasts wide therapeutic coverage from across 14 therapeutic areas. We also offer custom models, modifications to our existing models, and can even help you replicate models from the literature.

Explore our models or contact us for custom options.

Trusted by the Top Leaders in Pharmacology

Boehringer
Astellas
Takeda
Biogen
Teva
Giled
Merck
Daiichi
JJ
Glaxo
Addex
Astellas
Pfizer
LB

Phenotypic screening uncovers otherwise
unpredicted new uses for a drug

Our in vivo pharmacology contract research capabilities

In Vivo Services

We offer access to dozens of animal models of human disease. Our commitment to in vivo services since 2005 has made us a CRO of choice for hundreds of companies.

Our in vivo pharmacology contract research capabilities

In Vivo Pharmacology Platforms

The theraTRACE® and opioidTRACE® platforms are our phenotypic screening tools for drug repositioning, drug repurposing, and indications discovery.

About Melior

More than just a provider of in vivo pharmacology services, Melior is a pioneer of in vivo phenotypic screening and a leader in the area of drug repositioning.

Its proprietary theraTRACE® platform enables rapid and
cost-effective identification of new therapeutic potential
by systematically screening candidates in a diverse array
of validated in vivo disease models.

Logo 1

Serving the pharma industry since 2005

Logo 2

Thousands of completed studies

Logo 3

Hundreds of compounds evaluated

Logo 4

Dozens of animal models of human disease

“Melior provided State-of-the-art Preclinical Pharmacology Support for a period of nearly a year where a series of in vivo studies were completed on a weekly basis. The staff was extremely user-friendly, and the operational processes were excellent. I can recommend Melior without reservation.”

Richard DiMarchi, PhD
Cox Professor of Chemistry & Gill Chair in Biomolecular Sciences
Indiana University, Department of Chemistry

Recent Studies using Phenotypic Screening

Increasingly, phenotypic screening is being recognized as the best strategy to uncover otherwise unpredicted new uses of therapeutics.

A high-resolution phenotypic screen identifies regulators of CNS axon diameter in zebrafish

Maria A Eichel-Vogel, Daniel Y H Soong, Melody N Sequeira, Maya L A Ibenfeldt, Katy L H Marshall-Phelps, Jenea M Bin, David A Lyons

A phenotypic screen identifies xanthohumol and other flavonoids as killers of bladder cancer

Michael J Bolt, Jessica Oceguera, Alejandra Rivera Tostado, Christopher D Candler, Elina Mosa, Kazem Safari, Maureen G Mancini, Michael A Mancini